Market Research Logo

Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review

Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Physiomics plc (Physiomics) is a computational systems biology services company. It offers Virtual Tumour, which optimizes the dosing and scheduling of oncology drugs in pre-clinical trials, cardiac toxicity services through its EasyAP, a Web-based simulation and analysis tool. It also offers model based drug development services, which includes population PKPD analysis of clinical data, back-translational analysis, optimal design of future studies. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from pre-clinical research to clinical development and finding optimal schedules. The company provides consulting services for specific pharmaceutical development projects and provides trouble-shooting services for cancer projects. Physiomics partners with small and large pharmaceutical and biotechnology companies. Physiomics is headquartered at Oxford, England, the UK.

Physiomics Plc Key Recent Developments

Oct 08,2018: Physiomics: Final Results for the year ended 30 June 2018
Aug 09,2018: Physiomics signs agreement with new european biotech client
Jul 02,2018: Physiomics expands technical team
Apr 04,2018: Physiomics to Present at the American Association for Cancer Research (AACR) Annual Meeting
Mar 14,2018: Physiomics: Award of New Innovate UK Grant

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Physiomics Plc - Key Facts
Physiomics Plc - Key Employees
Physiomics Plc - Key Employee Biographies
Physiomics Plc - Major Products and Services
Physiomics Plc - History
Physiomics Plc - Company Statement
Physiomics Plc - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Physiomics Plc - Business Description
Physiomics Plc - Corporate Strategy
Physiomics Plc - SWOT Analysis
SWOT Analysis - Overview
Physiomics Plc - Strengths
Physiomics Plc - Weaknesses
Physiomics Plc - Opportunities
Physiomics Plc - Threats
Physiomics Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Physiomics Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 08, 2018: Physiomics: Final Results for the year ended 30 June 2018
Aug 09, 2018: Physiomics signs agreement with new european biotech client
Jul 02, 2018: Physiomics expands technical team
Apr 04, 2018: Physiomics to Present at the American Association for Cancer Research (AACR) Annual Meeting
Mar 14, 2018: Physiomics: Award of New Innovate UK Grant
Mar 12, 2018: Physiomics: Completion of Innovate UK Grant Project on Personalised Treatment of Oesophageal Cancer
Feb 19, 2018: Physiomics: Interim Results Statement for the six-month period ended 31 December 2017
Feb 09, 2018: Physiomics secures third major pharmaceutical client in matter of months
Jan 26, 2018: Physiomics: New Major Pharmaceutical Client
Nov 28, 2017: Completion of VT Clinical Project with Merck and announcement of Master Services Agreement
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Physiomics Plc, Key Facts
Physiomics Plc, Key Employees
Physiomics Plc, Key Employee Biographies
Physiomics Plc, Major Products and Services
Physiomics Plc, History
Physiomics Plc, Key Competitors
Physiomics Plc, Ratios based on current share price
Physiomics Plc, Annual Ratios
Physiomics Plc, Annual Ratios (Cont...1)
Physiomics Plc, Interim Ratios
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Physiomics Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Physiomics Plc, Performance Chart (2014 - 2018)
Physiomics Plc, Ratio Charts
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Physiomics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report